Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Karyotyping01:17

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
Karyotyping01:17

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Genetic Lingo01:11

Genetic Lingo

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interdisciplinary vascular genetics evaluations in routine clinical care: insights from a five-year single-center experience.

Langenbeck's archives of surgery·2026
Same author

Optimising rare tumour risk syndromes care: clinical insights and the PREVENTABLE socioeconomic framework.

European journal of human genetics : EJHG·2026
Same author

Genome Sequencing of Undiagnosed European Patients Suspected of Hereditary Cancer: Diagnostic Yield and Identification of Candidate Causative Variants.

JCO precision oncology·2026
Same author

Longitudinal Surveillance of Gastric Polyposis in Familial Adenomatous Polyposis: Incidence, Progression, and Endoscopic Outcomes.

United European gastroenterology journal·2026
Same author

Biallelic Germline Inactivation of HROB Causes Primary Gonadal Insufficiency and is Potentially Associated with Colonic Polyposis Predisposition.

American journal of medical genetics. Part A·2026
Same author

Case Report: A heterozygous loss-of-function variant of the <i>ERG</i> gene in a family with vascular pathologies.

Frontiers in cardiovascular medicine·2025
Same journal

Pathodashboard: an epidemiological atlas for tumour diagnostics.

Pathologie (Heidelberg, Germany)·2026
Same journal

Pathologie (Heidelberg, Germany)·2026
Same journal

Pathologie (Heidelberg, Germany)·2026
Same journal

[Guideline development for MRD diagnostics in AML as a blueprint for solid tumors].

Pathologie (Heidelberg, Germany)·2026
Same journal

[Therapy of melanoma : Current standards and future perspectives].

Pathologie (Heidelberg, Germany)·2026
Same journal

[Cutaneous clear cell sarcoma].

Pathologie (Heidelberg, Germany)·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

[Genetic diagnostics].

Laura Grohs1,2,3,4, Felix Marbach1,2,3,4, Stefan Aretz5,6,7,8

  • 1Institut für Humangenetik, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland.

Pathologie (Heidelberg, Germany)
|June 24, 2026
PubMed
Summary
This summary is machine-generated.

Early detection of hereditary tumor predisposition syndromes (TDS) is crucial for preventive oncology. Identifying pathogenic germline variants through tumor and germline sequencing aids in diagnosing families, enabling timely interventions.

Area of Science:

  • Oncology
  • Genetics
  • Preventive Medicine
Keywords:
Genome sequencingGermline variantsHereditary tumor syndromesPersonalised medicinePrevention

More Related Videos

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Related Experiment Videos

Last Updated: Jun 25, 2026

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016